Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
ERJ Open Research|August 29, 2017
Stratification of eosinophilic asthma patients treated with reslizumab and GINA Step 4 or 5 therapyGuy Brusselle, Janice Canvin, Sivan Weiss, et al.
The Annals of Pharmacotherapy|January 27, 2004
Cost comparisons of olanzapine and risperidone in treating schizophreniaGordon G Liu, Shawn X Sun, Dale B Christensen, et al.
Journal of General Internal Medicine|July 29, 2008
The impact of the Medicare Part D prescription benefit on generic drug useJames X Zhang, Wesley Yin, Shawn X Sun, et al.
Current Therapeutic Research, Clinical and Experimental|May 3, 2014
Choice of atypical antipsychotic therapy for patients with schizophrenia: An analysis of a medicaid populationGordon G Liu, Shawn X Sun, Dale B Christensen, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 23, 2015
Lower 30-day readmission rates with roflumilast treatment among patients hospitalized for chronic obstructive pulmonary diseaseAlex Z Fu, Shawn X Sun, Xingyue Huang, et al.
Journal of Managed Care & Specialty Pharmacy|December 28, 2016
Clinical and Economic Burden of Elevated Blood Eosinophils in Patients With and Without Uncontrolled AsthmaJulian Casciano, Jerry Krishnan, Zenobia Dotiwala, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 7, 2023
Outcomes in Patients With von Willebrand Disease Receiving Recombinant von Willebrand Factor on Demand and in Surgical Settings: Chart ReviewShawn X Sun, Shannely Lowndes, Rosa Willock, et al.
Current Medical Research and Opinion|August 19, 2007
Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United StatesShawn X Sun, Gordon G Liu, Dale B Christensen, et al.
Pageof 4